Characterization of biofilms on extracorporeal life support system (ECLS) cannulae and their relevance to bacteremia or fungemia.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024842

Enrollment

Registered

2021-04-12

Start date

2022-01-18

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A49.9 B49

Interventions

Group 1: Collections of data and examinations are performed on the day of ECLS decannulation.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Written informed consent by the study participant or the participant's legally appointed representative, older than 18 years, ECLS therapy

Exclusion criteria

Exclusion criteria: Refusal to participate in the study younger than 18 years

Design outcomes

Primary

Measure	Time frame
The primary objective of this study is to detect biofilms on the ECLS/ECMO cannulas.	—

Secondary

Measure	Time frame
In addition, it will be investigated whether the removal of the cannulas leads to bacteremia or fungemia.	—

Countries

Germany

Contacts

Public ContactSimone Kattner

Klinik für Anästhesiologie und Intensivmedizin Universitätsklinikum Essen

simone.kattner@uk-essen.de0201 723 1401

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026